ERBB2 and breast neoplasm: Breast tumor heterogeneity is a major cause of discordance between HER2 IHC and HER2 FISH assay results [16,17] and approximately 5-30% of HER2 positive breast cancer cases exhibit intratumoral genetic heterogeneity [18].